Skip to main content

Find Clinical Trials

Home
Conditions
Malignant Melanoma

Clinical trial condition

Malignant Melanoma

Explore clinical trials studying Malignant Melanoma. Study availability and eligibility vary by location and protocol.

168 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Malignant Melanoma trial results

Completed

Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

NCT01744860

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Boulogne-Billancourt, France

Colmar, France

Lille, France

Lyon, France

View Trial Details

Completed

Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors

NCT01455259

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Uppsala University Hospital Uppsala, Sweden

View Trial Details

Completed

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

NCT01435369

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Yale University School of Medicine, Section of Med Onc. New Haven, Connecticut, United States

Moffitt Cancer Center Cutaneous Oncology Department Tampa, Florida, United States

Northwestern Memorial Hospital Chicago, Illinois, United States

The University of Chicago Chicago, Illinois, United States

View all 18 locations

View Trial Details

Completed

A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma

NCT01107418

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: La Jolla, California, United States

San Francisco, California, United States

Stanford, California, United States

New Haven, Connecticut, United States

View all 13 locations

View Trial Details

Completed

Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma

NCT00978913

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Department of Oncology, Herlev University Hospital Herlev, Denmark

View Trial Details

Completed

A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2

NCT01480323

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: University Hospital Tübingen Tübingen, Germany

View Trial Details

Completed

Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors

NCT00855452

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +32 more
Locations: Hadassah University Hospital Jerusalem, Israel

View Trial Details

Completed

Comparison of Video-Based Versus Written Patient Education on Melanoma

NCT00826995

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of California Davis Department of Dermatology Sacramento, California, United States

View Trial Details

Completed

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

NCT00441337

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +52 more
Locations: Johns Hopkins Unv., School of Medicine Baltimore, Maryland, United States

Henry Ford Health System Detroit, Michigan, United States

Washington University School of Medicine - Barnes Jewish Hospital St Louis, Missouri, United States

Carolina BioOncology Institute, PLLC Huntersville, North Carolina, United States

View Trial Details

Completed

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

NCT01253096

Conditions: Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
Locations: Universitätsklinik Graz Graz, Austria

Medizinischen Hochschule Hannover Hanover, Germany

University Hospital Tübingen, Germany

View Trial Details